Wednesday, November 30, 2016

Valeant's Discussions to Sell Salix to Takeda Have Broken Down

Valeant’s talks to sell a stomach-drug business to Japan’s Takeda Pharmaceutical for roughly $10 billion have broken down.

from WSJ.com: US Business http://ift.tt/2fMqlh4
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)